Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 2/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
| ▸ | MMP14 | P50281 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4364577 | 0.88 | ALB (0.42) | ALBFOLH1DRD2MEN1KMT2A | |
| SCHEMBL15388951 | 0.82 | EPHX2 (0.36) | ALBNOD1DRD2EPHX2ASAH1 | |
| SCHEMBL4372295 | 0.81 | ALB (0.38) | ALBFOLH1 | |
| SCHEMBL15389358 | 0.81 | NAPEPLD (0.45) | — | |
| SCHEMBL15389537 | 0.80 | SOAT2 (0.46) | ALBEPHX2MEN1CNR1CNR2 | |
| SCHEMBL15389549 | 0.80 | SOAT2 (0.46) | ALBEPHX2MEN1CNR1CNR2 | |
| SCHEMBL4369094 | 0.79 | ALB (0.39) | ALBFOLH1 | |
| SCHEMBL4366967 | 0.79 | ALB (0.36) | ALBFOLH1 | |
| SCHEMBL23723184 | 0.78 | ALB (0.56) | ALBFOLH1NOD1EPHX2MMP2 | |
| SCHEMBL4364627 | 0.76 | ENPP2 (0.34) | ALBDRD2HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9770520-B2 | Chelate nanoemulsion for MRI | GUERBET (FR) | 2017-09-26 | — | — | US | disclosed |
| US-20130309176-A1 | CHELATE NANOEMULSION FOR MRI | UNIVERSITE DE BORDEAUX 1 (FR) | 2013-11-21 | — | — | US | disclosed |
| US-8268810-B2 | Lipophilic chelates and their use in imaging | GUERBET (FR) | 2012-09-18 | — | — | US | disclosed |
| US-20090214441-A1 | Lipophilic Chelates and Their Use in Imaging | GUERBET (FR) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090214441-A1 | Lipophilic Chelates and Their Use in Imaging | SLC40A1, TSPO, SLC47A2 | ALB 1926/4885FOLH1 186/4885NOD1 2456/4885 |
| US-20130309176-A1 | CHELATE NANOEMULSION FOR MRI | SGMS1, SGMS2, PHOSPHO1 | ALB 149/4885FOLH1 1125/4885NOD1 3584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.